Fig. 1From: Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinomaThe study sample division chart. The studied patents samples were divided into two categories. The first category was composed of 14 individuals (test group) which were participated in LNA-array probe test and were composed of 5 rejected and 9 nonrejected samples. The second group was consisted of 30 individuals (validation group). These patient samples were used for validating the results of LNA-array testBack to article page